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Edward K Geissler1* and Alan Jardine2The field of organ, tissue and cell transplantation
through the recent decades has revolutionised treatment
options for some of the most critically ill patients.
Advancements in this discipline have been dramatic and
provided life saving options, with a good quality of life,
for patients with previously untreatable conditions. Both
researchers and the public remain fascinated with the
concept of transplantation because replacing body parts
still seems to be part of science fiction, but yet is some-
how possible through extraordinary pioneering research
that has become part of routine modern medicine.
Nonetheless, many serious issues remain unsolved limit-
ing the further advancement of transplantation medicine,
including the severe shortage of available organs/tissues
and our inability to prevent immunological rejection
without life-long suppression of general immunity with
drugs that have substantial side-effects. Indeed, it could
be said that the field of transplantation is presently rest-
ing uncomfortably on a plateau that most clinicians and
researchers feel is far from where we would like to be
[1]. Striving for adequate organ availability and preserv-
ing long term graft function are principal goals for the
coming decades. This will require intensive and innova-
tive basic and clinical research.
Providing new, reliable, rapid and fully open avenues
for publishing transplantation research will only add to
our ability to advance transplantation science and the
care of transplant recipients. We believe that the advent
of “open access publishing” brings a fresh perspective to
publishing novel research; Transplantation Research
aims to contribute to this niche by providing all the po-
tential benefits that open access publishing has to offer.
Among the advantages are speed of publication (pub-
lished immediately upon acceptance), high visibility of
your research (anyone with web access can read your
article free of charge), and the provision of unlimited
space for figures and extensive data sets (including
video). With Transplantation Research, all articles will
be rigorously peer reviewed by our outstanding global* Correspondence: Edward.Geissler@klinik.uni-regensburg.de
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use, distribution, and reproduction in anyeditorial board [2], and other ad hoc experts in the field.
These combined values provided by open access pub-
lishing have been recognised by numerous societies
[3,4], national authorities and institutions, many of
which now cover publication costs that guarantee open
public access [5]. For example, both of our own aca-
demic institutions are participants of BioMed Central
open access publishing, covering all publication costs.
In Germany, the primary scientific funding agency, the
Deutsche Forschungsgemeinschaft (DFG), supports
open access publishing by offering also to fund publica-
tion costs. Similarly, the European Commission strongly
and actively advocates open access publishing of results
from their funded projects. These are unmistakeable
signals that the time and technology has come to bring
our research results to all researchers, regardless of
their local library funding resources, and to the general
public. Moreover, it is recognition that public funding
supports most research and that the public should have
open access to the work they are paying for [6]. There-
fore, we have taken on the task of establishing the jour-
nal Transplantation Research to help fulfil a mandate
in transplantation to provide more full access to
current knowledge in the field.
Transplantation Research is meant to be a portal for
all aspects of transplantation investigation. We encour-
age the publication of studies involving a wide range of
transplantation research, including: organ preservation,
ischemia-reperfusion injury, histocompatibility, experi-
mental immunosuppression, immune recognition -
regulation, tolerance induction strategies, stem cell re-
search for tissue regeneration and immune regulation,
clinical trials, complications of transplantation (e.g. graft
dysfunction, tissue repair, infections and posttransplant
malignancy), biomarker investigation, organ donation
and transplantation ethics, as well as xenotransplant-
ation. We at Transplantation Research will encourage the
publication of experimental research and pilot clinical
trials that introduce new ideas and concepts to the field
of transplantation. The introduction of novel experimen-
tal concepts that may have not yet been fully tested and
early stage trial results are welcomed for publication and
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publication portal for presentation and discussion of trial
designs is largely missing in transplantation. Further-
more, we also encourage the publication of new and in-
novative experimental methods that can help other
investigators establish reliable models and measures in
their research. Finally, with the support of our publisher,
BioMed Central, we will be adding a new publication
media dimension to transplantation, by offering the pos-
sibility of a “video-type” publication (e.g. surgical meth-
ods, experimental procedures). Therefore, with the
increasingly powerful platform of electronic open access
publishing, we aim with Transplantation Research to
offer all transplantation researchers new and innovative
possibilities for publishing their basic and clinical studies.
There is also another perspective to consider – regarding
the introduction of another journal in the field of trans-
plantation. Simply stated, it is important that researchers
have options to present their work to a different group of
editors that inherently may consider studies to have more,
or less, priority. How often have each of us sent for publi-
cation what we believed to be important and well-designed
studies to one group of editors, only to be outwardly
rejected, and turned around to send the work to another
editorial group where the work was well received. It is not
even uncommon for studies that were first sent for publi-
cation in a lower-ranking journal to be accepted later in a
higher ranking journal, where the latter editors judge the
study to be of a higher priority. This is normal and to be
expected in the “business” of research publication; having
multiple options, as long as journals use a solid and rigor-
ous peer-review process, can only be positive for the devel-
opment of the field.
We trust that our own expertise and views, and those of
our editorial board, can indeed offer a fresh opinion and
option for publishing your transplantation research. More-
over, we firmly believe that Transplantation Research,
built on a foundation of an open access publishing instru-
ment, also offers new publication categories, as well new
innovative publishing formats, to transplant researchers.
Importantly, we can ensure that the information is made
freely available to all researchers, and the public sector.
To us, this is a worthwhile endeavour that we hope will
contribute to the improvement of outcomes following
transplantation.
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